Trademark: 79109037
Status Date
Wednesday, June 15, 2022
Registration Number
4252171
Registration Date
Tuesday, December 4, 2012
Filing Date
Monday, October 24, 2011
Published for Opposition
Tuesday, September 18, 2012
5 Pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, namely, for the treatment of cancer; capsules and particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials for medical and pharmaceutical purposes for the treatment of cancer; chemical preparations for medical and pharmaceutical purposes for the treatment of cancer; chemical preparations for veterinary purposes for the treatment of cancer; drugs for medical purposes for the treatment of cancer; microcapsules for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials containing radioactive material for medical therapeutic use for the treatment of cancer; microcapsules containing pharmaceutical, veterinary or medical preparations for the treatment of cancer; microcapsules and microparticles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials adapted to selectively deliver material, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials and microcapsules for the treatment of cancer; microscopic particles in the nature of radio-isotopes, radionuclides, chemotherapeutic agents and magnetic materials adapted to selectively deliver material, including radioactive materials, chemical agents and heat, to a target site such as a cell or organ for the treatment of cancer
42 Medical research; scientific research for medical purposes; research and development of medical and veterinary products for medical and veterinary purposes, including pharmaceuticals, microcapsules, microparticles, radioactive materials, chemical agents and preparations, cancer treatments and treatments for diseased cells; medical and scientific research relating to molecular sciences, pharmaceuticals, drugs, chemicals and biotechnology
Color is not claimed as a feature of the mark.
Jun 15, 2022
Notice Of Acceptance Of Sec. 71 - E-Mailed
Jun 15, 2022
Registered-Sec.71 Accepted
May 31, 2022
Case Assigned To Post Registration Paralegal
May 9, 2022
Limitation From The Ib Examined, No Action Is Needed
May 9, 2022
Limitation From The Ib Examined, No Action Is Needed
Apr 2, 2022
Restriction Of Holder's Right Of Disposal Received
Apr 2, 2022
Restriction Of Holder's Right Of Disposal Received
Dec 5, 2021
Teas Section 71 Received
Dec 4, 2021
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Nov 11, 2021
International Registration Renewed
Apr 9, 2021
New Representative At Ib Received
Dec 27, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 27, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 30, 2019
Limitation From The Ib Examined, No Action Is Needed
Jan 24, 2019
Restriction Of Holder's Right Of Disposal Received
Apr 24, 2018
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Apr 24, 2018
Registered - Sec. 71 Accepted & Sec. 15 Ack.
Apr 24, 2018
Case Assigned To Post Registration Paralegal
Apr 3, 2018
Teas Section 71 & 15 Received
Mar 25, 2013
Final Decision Transaction Processed By Ib
Mar 6, 2013
Final Disposition Notice Sent To Ib
Mar 6, 2013
Final Disposition Processed
Mar 4, 2013
Final Disposition Notice Created, To Be Sent To Ib
Dec 4, 2012
Registered-Principal Register
Oct 16, 2012
Notification Processed By Ib
Sep 18, 2012
Published For Opposition
Aug 29, 2012
Notification Of Possible Opposition Sent To Ib
Aug 29, 2012
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 29, 2012
Notice Of Publication
Aug 14, 2012
Law Office Publication Review Completed
Aug 13, 2012
Examiners Amendment Mailed
Aug 13, 2012
Approved For Pub - Principal Register
Aug 13, 2012
Examiner's Amendment Entered
Aug 13, 2012
Examiners Amendment -Written
Aug 2, 2012
Teas/Email Correspondence Entered
Aug 2, 2012
Correspondence Received In Law Office
Jul 20, 2012
Assigned To Lie
Jul 18, 2012
Teas Response To Office Action Received
Jul 17, 2012
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 17, 2012
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 24, 2012
Refusal Processed By Ib
Mar 1, 2012
Non-Final Action Mailed - Refusal Sent To Ib
Mar 1, 2012
Refusal Processed By Mpu
Feb 29, 2012
Non-Final Action (Ib Refusal) Prepared For Review
Feb 28, 2012
Non-Final Action Written
Feb 28, 2012
Application Filing Receipt Mailed
Feb 24, 2012
Assigned To Examiner
Feb 24, 2012
New Application Office Supplied Data Entered In Tram
Feb 23, 2012
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
